Company / Assets per Share
SAB Biotherapeutics, Inc. Assets per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$18.60
FY2025
5-year range
$2.18 / $18.60
FY2021-FY2025
Trend
+288.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share changed +288% YoY in FY2025, a notable deviation from the 4-year average annual change of +173%.
Based on SEC 10-K filings.
18.60 in FY2025 with a 3-year CAGR of +81.3%.
Improved from $16.65 to $18.60 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +81.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, assets per share increased 288.3% year-over-year.
- Lowest assets per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.31 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $18.60 | +288.3% |
| FY2024 | $4.79 | -71.2% |
| FY2023 | $16.65 | +433.1% |
| FY2022 | $3.12 | +43.5% |
| FY2021 | $2.18 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026